Weekly Recap | Twist Bioscience +3.19%, consensus target below spotWeekly Review·Oct 3, 2026 at 08:40 AMTWST-6.78%
Weekly Recap | Alnylam Pharma -14.16%, one-way sellingWeekly Review·Oct 3, 2026 at 08:28 AMALNY+0.21%
Weekly Recap | RXRX.US +10.16%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:37 AMRXRX-7.78%
Weekly Recap | Roche -4.04%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:34 AMRHHBY+2.89%
Weekly Recap | PURR.US -7.47%, consensus target above spotWeekly Review·Oct 3, 2026 at 07:30 AMPURR-6.16%
The Nasdaq Biotechnology Index fell by approximately 1.7%. Among the constituent stocks, Regenxbio dropped 17.90%, Altimmune fell 17.15%, Jyong Biotech decreased by 15.95%, Coherus BioSciences declined 11.75%, Relay Therapeutics Inc fell 10.06%, and Maravai Lifesciences dropped 10.00%. Meanwhile, Apellis Pharma rose 5.82%, Kodiak Sciences increased by 6.28%, Alumis went up 6.58%, and Zenas Biopharma gained 7.03%Wallstreetcn·Jan 28, 2026 at 11:57 PMRGNX+1.95%BBH+0.67%
